The findings come amidst growing use of the treatment approach. Neoadjuvant chemotherapy (NACT) may be associated with poorer survival outcomes for certain patients with more uncommon types of ...

High-volume cancer centers with greater NACT use show reduced 90-day surgical mortality and improved 60-month survival for advanced-stage ovarian cancer patients. The study analyzed data from the ...

Receiving treatment at a center with greater use of neoadjuvant chemotherapy was associated with a lower risk of 90-day mortality for patients treated at low-, average-, or high-volume centers.

Neoadjuvant chemotherapy (NACT) is a treatment for advanced ovarian cancer – cancer at stage III or IV. It uses chemo drugs to shrink tumors before any surgery is done to remove them. NACT uses a ...

—There has been a shift toward greater use of neoadjuvant chemotherapy in patients with advanced ovarian cancer. Is it the right choice? Reviewed by Vrunda Bhavsar Desai, MD, FACOG, Adjunct Assistant ...

Improved Metastasis-Free and Survival Outcomes With Early Salvage Radiotherapy in Men With Detectable Prostate-Specific Antigen After Prostatectomy for Prostate Cancer A multi-institutional ...

Re-excision rates among older breast cancer patients undergoing breast-conserving surgery (BCS): Impact of the SSO-ASTRO consensus guideline on margins. Four-year follow-up of a phase III study ...

Increased use of neoadjuvant chemotherapy appeared associated with improvements in short-term mortality without sacrificing long-term survival in ovarian cancer, according to a comparative ...

Gastric cancer is a common malignant tumor that originates from the gastric mucosal epithelium. Being insidious and non-specific, the early-stage symptoms of the cancer are similar to that of chronic ...